HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Morbidity-associated factors after gastrojejunostomy for malignant gastric outlet obstruction.

Abstract
Palliative care of malignant gastric outlet obstruction symptoms is critical for improved quality of life. We reviewed 66 consecutive patients with malignant gastric outlet obstruction who underwent palliative gastrointestinal bypass. The objective was to analyze morbidity and mortality-associated factors of this surgical procedure. Surgical morbidity and mortality were 39 per cent and 31 per cent, respectively. Reintervention was necessary in 16.6 per cent of cases. The only variable associated with surgical mortality was a Karnofsky score less than 80 (P = 0.02). Median survival of patients was 4 months (range, 2.11-5.9 months). Variables associated with shorter survival rates were an advanced stage of the disease and a Karnofsky score less than 80. Nine of 45 (20%) patients who survived after the gastrointestinal bypass surgery were unable to tolerate a normal diet. Palliative gastrojejunostomy in patients with malignant gastric outlet obstruction is associated with high morbidity and mortality; it is necessary to improve nonsurgical options such as endoscopic stenting.
AuthorsHeriberto Medina-Franco, Leonardo Abarca-Pérez, Nayví España-Gómez, Noel Salgado-Nesme, Laura J Ortiz-López, Miriam N García-Alvarez
JournalThe American surgeon (Am Surg) Vol. 73 Issue 9 Pg. 871-5 (Sep 2007) ISSN: 0003-1348 [Print] United States
PMID17939415 (Publication Type: Journal Article)
Topics
  • Digestive System Neoplasms (complications)
  • Female
  • Gastric Outlet Obstruction (mortality, surgery)
  • Gastrostomy
  • Humans
  • Jejunostomy
  • Length of Stay (statistics & numerical data)
  • Male
  • Middle Aged
  • Palliative Care (methods)
  • Postoperative Complications (mortality)
  • Quality of Life
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: